Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

NCT00360490 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Menorrhagia

Interventions

DRUG: Levonorgestrel IUS (Mirena, BAY86-5028)
DRUG: Medroxyprogesterone acetate

Sponsor

Bayer